Mid-Atlantic Issues Advisory on Two Drugs: The Blood-Horse 7/21/15

By Tom LaMarra West Virginia has joined other states in the Mid-Atlantic region in posting an advisory regarding use of two therapeutic drugs that can be problematic for horsemen. The advisory stemmed from a Mid-Atlantic regulatory meeting earlier in July at which the progress of the National Uniform Medication Program was discussed. Participants identified two

OBS Adopting Model Medication Rules: The Blood-Horse 2/10/15

By Blood-Horse Staff The Ocala Breeders' Sales Co. will begin implementing guidelines for controlled therapeutic medications at its 2-year-olds in training under-tack shows this spring that follow the uniform medication model rules created by the Association of Racing Commissioners International. Starting with its March 2-year-olds in training sale's under-tack show March 11-13, the Central Florida

RMTC Board Recommends Therapeutic Withdrawal Times, Grants First Interim Lab Accreditation 3/21/13

NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association

RMTC Board Approves Plans for Threshold Research and BET Team Security in 2006 2/8/06

February 8, 2006-The Board of Directors of the Racing Medication and Testing Consortium (RMTC) on Tuesday approved a plan developed by Dr. Rick Sams of The Ohio State University to establish guidelines for withdrawal times for therapeutic medications commonly utilized by race track veterinarians. The RMTC board meeting was held in Las Vegas in conjunction